A new drug offers a breakthrough world first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke, announced today by study lead Professor Stephen Nicholls, ...
Aug 28, 2023
0
70
Increased levels of lipoprotein(a), a variant of "bad cholesterol" in the bloodstream, are a risk factor for recurrent coronary heart disease (CHD) in people aged 60 or over, according to the results of a new study which ...
Jun 13, 2023
0
93
High levels of lipoprotein(a), a type of "bad" cholesterol, may be associated with an 18-20% higher risk of cardiovascular disease among people who have hypertension, however, CVD risk was not higher among those without hypertension, ...
Dec 13, 2022
0
88
Lipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological therapies to decrease its concentration in the bloodstream. Olpasiran is an investigational ...
Nov 7, 2022
1
88
